AIM ImmunoTech Inc (AIM)
0.43
0.00 (0.00%)
USD |
NYAM |
Apr 24, 16:00
0.428
0.00 (0.00%)
After-Hours: 20:00
AIM ImmunoTech Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.0033 |
| December 31, 2020 | 0.0038 |
| September 30, 2020 | 0.0037 |
| June 30, 2020 | 0.0047 |
| March 31, 2020 | 0.1257 |
| December 31, 2019 | 0.3068 |
| September 30, 2019 | 0.3316 |
| June 30, 2019 | 0.38 |
| March 31, 2019 | 0.9369 |
| December 31, 2018 | 0.6971 |
| September 30, 2018 | 0.526 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.0218 |
| December 31, 2017 | 0.2108 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.146 |
| June 30, 2017 | 0.05 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.2193 |
| June 30, 2013 | 0.1951 |
| March 31, 2013 | 0.1704 |
| December 31, 2012 | 0.1577 |
| September 30, 2012 | 0.1574 |
| June 30, 2012 | 0.1293 |
| March 31, 2012 | 0.063 |
| December 31, 2011 | 0.0446 |
| September 30, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2021
0.38
Maximum
Jun 2019
0.061
Average
--
Median
Jun 2021
Debt to Equity Ratio Benchmarks
| Perspective Therapeutics Inc | 0.0229 |
| Protalix BioTherapeutics Inc | 0.6033 |
| Electromed Inc | 0.00 |
| Xtant Medical Holdings Inc | 0.4243 |
| Armata Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 19.38M |
| Total Liabilities (Quarterly) | 9.147M |
| Shareholders Equity (Quarterly) | 10.23M |
| Current Ratio | 1.682 |